Pre-Market After Hours Real-Time QuotesDelayed QuotesStock HaltedLearn More >>

Genentech Inc. DNA (NYSE)

7:36pm 01/15/2009Pre-Market After Hours $84.47Change: -0.61 -0.72%Volume: 35,145

$85.08

Change:-0.49 -0.57%

Volume:3,745,904

4:01pm 01/15/2009

Open:

$84.15

Shares Out:

1.05B

P/E:

24.88

High:

$85.91

Market Cap:

$89.51B

EPS:

3.42

Low:

$83.59

52-Wk High:

08/14$99.14

Dividend:

N/A

Prev. Close:

$85.57

52-Wk Low:

01/23$66.50

Yield:

N/A

Avg Volume:

3.49M

Ex Date:

N/A

Alert Me for News on DNA

MarketWatch News on DNA

7:34 PM today	Stocks to Watch: Stocks in focus for Friday - by MarketWatch
6:42 PM today	After Hours: Intel shares advance following in-line results; Genentech lower - by Carla Mozee
6:25 PM today	Market Wrap: Thursday - by Anthony Lazarus
6:23 PM today	Market Update: After the bell report from MarketWatch Radio Network - by Steve Orr
6:14 PM today	Genentech earnings rise 47% on strong sales of anti-cancer drug - by Dan Gallagher
4:31 PM today	Earnings Watch: Updates, advisories and surprises - by MarketWatch
4:30 PM today	Genentech late-shares down 0.7% to $84.50 in light volume - MarketWatch
4:08 PM today	Genentech earnings jump 47% in fourth quarter - by Dan Gallagher

News PageOlder NewsNewer News

More News on DNA

10:54 PM today	Genentech Net Surges ; Outlook Disappoints - WSJ.com
8:23 AM today	Q4 Earnings: How Will Sectors Stack Up? - BusinessWeek
11:02 PM 1/14/09	Investors Hope Chase's Dimon Changes Tune - WSJ.com
8:30 AM 1/14/09	Stocks End Mixed amid Earnings Worries - BusinessWeek
3:22 AM 1/14/09	The Recession Damages R&D Spending (AAPL)(PFE)(MSFT)(GOOG)(DNA) - 247wallst.com
8:27 AM 1/13/09	Marcial: Best Biotechs for 2009 - BusinessWeek
11:23 PM 1/12/09	Stocks Fall Again in Europe and Asia - WSJ.com
10:38 PM 1/12/09	Roche Says Genentech Bid on Track - WSJ.com

News PageOlder NewsNewer News

Press Releases on DNA

5:45 PM today	Curis Announces Genentech's Expected Initiation of Pivotal Phase II Trial in Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitor - BusinessWire
4:02 PM today	Genentech Announces Full Year and Fourth Quarter 2008 Results - BusinessWire
8:00 AM today	APT Pharmaceuticals Adds Stephen Aselage to Board of Directors - BusinessWire
1:30 PM 1/14/09	Bioscience Group Identifies Trends for 2009 - BusinessWire
10:00 AM 1/7/09	Former Genentech Associate Director and Wilson Sonsini Attorney, Stacy Feld, Joins Physic Ventures Team as Director - BusinessWire
1:29 PM 12/30/08	Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients - PR Newswire
5:00 PM 12/22/08	Genentech Announces January 15 Webcast of Financial and Other Business Results - BusinessWire
1:30 AM 12/19/08	Phase III Study Showed Rituxan(R) Decreased the Progression of Joint Damage in Patients with Early Rheumatoid Arthritis (RA) - BusinessWire

News PageOlder NewsNewer News

Compare DNA to:

S&P 500

DJIA

NASDAQ

Chart:1D|5D|1Mo|3Mo|6Mo|1Yr|2Yr

The Wall Street Journal Digital Network:

By using this site, you agree to the Terms of Service and Privacy Policy .

MarketWatch.com: Stock Market Quotes - Business News - Financial News

Intraday data provided by Interactive Data Real Time Services, a division of Interactive Data Corp. and subject to terms of use. Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data. More information on NASDAQ traded symbols and their current financial status. Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Dow Jones Indexes(SM) from Dow Jones & Company, Inc. SEHK intraday data is provided by Comstock and is at least 60-minutes delayed. All quotes are in local exchange time. Real-time last sale data provided by NASDAQ.